ghk cu synergy with gh igf 1 The GH/IGF-1 axis in ageing and longevity The GH/IGF-1 axis in obesity:
Description
Or getting out of the EU lol...That's the plan

Some suggest splitting doses, others insist on single morning administration

K., Hoch, J

However, clinical evidence from meta-analyses is limited and controversial, with potential inferiority as compared to pioglitazone [168, 169]

Support recovery with adequate protein intake and micronutrient-rich foods